综述 |
|
|
|
|
杜氏肌营养不良疾病模型及基因治疗研究进展 |
李统宇1,2, 梁平1,2 |
1. 浙江大学医学院附属第一医院肝胆胰外科 卫生部多器官联合移植研究重点实验室 浙江省器官移植重点实验室, 浙江 杭州 310003;
2. 浙江大学转化医学研究院, 浙江 杭州 310029 |
|
Research progress on disease models and gene therapy of Duchenne muscular dystrophy |
LI Tongyu1,2, LIANG Ping1,2 |
1. Division of Hepatobilitary and Pancreatic Surgery, the First Affiliated Hospital, Zhejiang University School of Medicine;Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health;Key Laboratory of Organ Transplantation, Zhejiang Province, Hangzhou 310003, China;
2. Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China |
[1] |
GOVONI A, MAGRI F, BRAJKOVIC S, et al. Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy[J]. Cell Mol Life Sci, 2013, 70(23):4585-4602.
|
[2] |
DAVIES K E, SMITH T J, BUNDEY S, et al. Mild and severe muscular dystrophy associated with deletions in Xp21 of the human X chromosome[J]. J Med Genet, 1988, 25(1):9-13.
|
[3] |
KUNKEL L M, MONACO A P, MIDDLESWORTH W, et al. Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion[J]. Proc Natl Acad Sci U S A, 1985, 82(14):4778-4782.
|
[4] |
PRIOR T W, BRIDGEMAN S J. Experience and strategy for the molecular testing of Duchenne muscular dystrophy[J]. J Mol Diagn, 2005, 7(3):317-326.
|
[5] |
MAGRI F, GOVONI A, D'ANGELO M G, et al. Genotype and phenotype characterization in a large dystrophinopathic cohort with extended follow-up[J]. J Neurol, 2011, 258(9):1610-1623.
|
[6] |
MUNTONI F, TORELLI S, FERLINI A. Dystrophin and mutations:one gene, several proteins, multiple phenotypes[J]. Lancet Neurol, 2003, 2(12):731-740.
|
[7] |
LAPIDOS K A, KAKKAR R, MCNALLY E M. The dystrophin glycoprotein complex:signaling strength and integrity for the sarcolemma[J]. Circ Res, 2004, 94(8):1023-1031.
|
[8] |
HENDRIKSEN R G, HOOGLAND G, SCHIPPER S, et al. A possible role of dystrophin in neuronal excitability:a review of the current literature[J]. Neurosci Biobehav Rev, 2015, 51:255-262.
|
[9] |
EHMSEN J, POON E, DAVIES K. The dystrophin-associated protein complex[J]. J Cell Sci, 2002, 115(Pt 14):2801-2803.
|
[10] |
DAVIES K E, NOWAK K J. Molecular mechanisms of muscular dystrophies:old and new players[J]. Nat Rev Mol Cell Biol, 2006, 7(10):762-773.
|
[11] |
GAO Q Q, MCNALLY E M. The dystrophin complex:structure, function, and implications for therapy[J]. Compr Physiol, 2015, 5(3):1223-1239.
|
[12] |
GUMERSON J D, MICHELE D E. The dystrophin-glycoprotein complex in the prevention of muscle damage[J]. J Biomed Biotechnol, 2011, 2011:210797.
|
[13] |
BULFIELD G, SILLER W G, WIGHT P A, et al. X chromosome-linked muscular dystrophy (mdx) in the mouse[J]. Proc Natl Acad Sci U S A, 1984, 81(4):1189-1192.
|
[14] |
MATSUMURA K, ERVASTI J M, OHLENDIECK K, et al. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle[J]. Nature, 1992, 360(6404):588-591.
|
[15] |
CHAMBERLAIN J S, METZGER J, REYES M, et al. Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma[J]. FASEB J, 2007, 21(9):2195-2204.
|
[16] |
WILLMANN R, POSSEKEL S, DUBACH-POWELL J, et al. Mammalian animal models for Duchenne muscular dystrophy[J]. Neuromuscul Disord, 2009, 19(4):241-249.
|
[17] |
LARCHER T, LAFOUX A, TESSON L, et al. Characterization of dystrophin deficient rats:a new model for Duchenne muscular dystrophy[J/OL]. PLoS One, 2014, 9(10):e110371.
|
[18] |
GIBBS E M, HORSTICK E J, DOWLING J J. Swimming into prominence:the zebrafish as a valuable tool for studying human myopathies and muscular dystrophies[J]. FEBS J, 2013, 280(17):4187-4197.
|
[19] |
BARTHÉLÉMY I, PINTO-MARIZ F, YADA E, et al. Predictive markers of clinical outcome in the GRMD dog model of Duchenne muscular dystrophy[J]. Dis Model Mech, 2014, 7(11):1253-1261.
|
[20] |
FAIRCLOUGH R J, WOOD M J, DAVIES K E. Therapy for Duchenne muscular dystrophy:renewed optimism from genetic approaches[J]. Nat Rev Genet, 2013, 14(6):373-378.
|
[21] |
AL-ZAIDY S, RODINO-KLAPAC L, MENDELL J R. Gene therapy for muscular dystrophy:moving the field forward[J]. Pediatr Neurol, 2014, 51(5):607-618.
|
[22] |
KOO T, WOOD M J. Clinical trials using antisense oligonucleotides in duchenne muscular dystrophy[J]. Hum Gene Ther, 24(5):479-488.
|
[23] |
AARTSMA-RUS A, FOKKEMA I, VERSCHUUREN J, et al. Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations[J]. Hum Mutat, 2009, 30(3):293-299.
|
[24] |
OUSTEROUT D G, KABADI A M, THAKORE P I, et al. Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleases[J]. Mol Ther, 2015, 23(3):523-532.
|
[25] |
URNOV F D, REBAR E J, HOLMES M C, et al. Genome editing with engineered zinc finger nucleases[J]. Nat Rev Genet, 2010, 11(9):636-646.
|
[26] |
OUSTEROUT D G, PEREZ-PINERA P, THAKORE P I, et al. Reading frame correction by targeted genome editing restores dystrophin expression in cells from Duchenne muscular dystrophy patients[J]. Mol Ther, 2013, 21(9):1718-1726.
|
[27] |
PERKINS K J, DAVIES K E. The role of utrophin in the potential therapy of Duchenne muscular dystrophy[J]. Neuromuscul Disord, 2002, 12 Suppl 1:S78-S89.
|
[28] |
TINSLEY J, DECONINCK N, FISHER R, et al. Expression of full-length utrophin prevents muscular dystrophy in mdx mice[J]. Nat Med, 1998, 4(12):1441-1444.
|
[29] |
DI CMG, CORBI N, STRIMPAKOS G, et al. The artificial gene Jazz, a transcriptional regulator of utrophin, corrects the dystrophic pathology in mdx mice[J]. Hum Mol Genet, 2010, 19(5):752-760.
|
[30] |
BASU U, LOZYNSKA O, MOORWOOD C, et al. Translational regulation of utrophin by miRNAs[J/OL]. PLoS One, 2011, 6(12):e29376.
|
[31] |
JINEK M, CHYLINSKI K, FONFARA I, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity[J]. Science, 2012, 337(6096):816-821.
|
[32] |
MENDELL J R, RODINO-KLAPAC L R. Duchenne muscular dystrophy:CRISPR/Cas9 treatment[J]. Cell Res, 2016, 26(5):513-514.
|
[33] |
TABEBORDBAR M, ZHU K, CHENG J K, et al. In vivo gene editing in dystrophic mouse muscle and muscle stem cells[J]. Science, 2016, 351(6271):407-411.
|
[34] |
CHAKKALAKAL J V, THOMPSON J, PARKS R J, et al. Molecular, cellular, and pharmacological therapies for Duchenne/Becker muscular dystrophies[J]. FASEB J, 2005, 19(8):880-891.
|
[35] |
EVANS M J, KAUFMAN M H. Establishment in culture of pluripotential cells from mouse embryos[J]. Nature, 1981, 292(5819):154-156.
|
[36] |
THOMSON J A, ITSKOVITZ-ELDOR J, SHAPIRO S S, et al. Embryonic stem cell lines derived from human blastocysts[J]. Science, 1998, 282(5391):1145-1147.
|
[37] |
DENNIS C. Cloning:mining the secrets of the egg[J]. Nature, 2006, 439(7077):652-655.
|
[38] |
HALL V J, STOJKOVIC P, STOJKOVIC M. Using therapeutic cloning to fight human disease:a conundrum or reality?[J]. Stem Cells, 2006, 24(7):1628-1637.
|
[39] |
KAZUKI Y, HIRATSUKA M, TAKIGUCHI M, et al. Complete genetic correction of ips cells from Duchenne muscular dystrophy[J]. Mol Ther, 2010, 18(2):386-393.
|
[40] |
NOGUCHI H, SAITOH I, TSUGATA T, et al. Induction of tissue-specific stem cells by reprogramming factors, and tissue-specific selection[J]. Cell Death Differ, 2015, 22(1):145-155.
|
[41] |
CHEN F, CAO J, LIU Q, et al. Comparative study of myocytes from normal and mdx mice iPS cells[J]. J Cell Biochem, 2012, 113(2):678-684.
|
[42] |
LUO Y, FAN Y, CHEN X, et al. Modeling induced pluripotent stem cells from fibroblasts of Duchenne muscular dystrophy patients[J]. Int J Neurosci, 2014, 124(1):12-21
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|